inaqovi
otsuka pharmaceutical netherlands b.v. - cedazuridine, decitabine - leucemie mieloidă - agenți antineoplazici - inaqovi is indicated as monotherapy for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) who are ineligible for standard induction chemotherapy.
rxulti
otsuka pharmaceutical netherlands b.v. - brexpiprazole - schizofrenie - psiholeptice - tratamentul schizofreniei.
abilify maintena
otsuka pharmaceutical netherlands b.v. - aripiprazol - schizofrenie - psiholeptice - tratamentul de întreținere a schizofreniei la pacienții adulți stabilizat cu aripiprazol pe cale orală.
carteol 2%
s.i.f.i. spa - carteololum - picaturi oft.-sol. - 20mg/ml - antiglaucomatoase si miotice medicamente betablocante
fat emulsie 200 mg/ml emulsie perfuzabilă
china sinopharm international corporation - soiae ulei raffinatum - emulsie perfuzabilă - 200 mg/ml
carteol 20mg/ml
s.i.f.i. spa - carteololum - picaturi oft.-sol. - 20mg/ml - antiglaucomatoase si miotice medicamente betablocante
abilify maintena 400mg
h. lundbeck a/s - danemarca - aripiprazolum - pulb.+solv. pt. susp. inj. cu elib. prel. - 400mg - antipsihotice alte antipsihotice
jinarc 15mg + jinarc 45mg
almac pharma services (ireland) limited - irlanda - tolvaptan - compr. - alte diuretice antagonisti ai vasopresinei
jinarc 30mg + jinarc 60mg
almac pharma services (ireland) limited - irlanda - tolvaptan - compr. - alte diuretice antagonisti ai vasopresinei
jinarc 30mg + jinarc 90mg
almac pharma services (ireland) limited - irlanda - tolvaptan - compr. - alte diuretice antagonisti ai vasopresinei